Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Hongbo Chemical is a Chinese chemical manufacturer focused on pharmaceutical intermediates and fine chemicals. The company describes itself as engaged in the research, development, production, and marketing of pharmaceutical intermediates, with manufacturing capabilities spanning multiple specialized reaction types and scale-up workshops. Reported products and capabilities include intermediates such as 2-chloropyridine, 2,6-dichloropyridine, 2-mercaptopyridine-N-oxide sodium salt, and Vince Lactam. Based on available public information, it appears to operate primarily as a commercial manufacturing and supply company rather than a therapeutics developer with a clinical pipeline. For biotech and pharma market mapping, it is best categorized as a small-molecule intermediate and fine-chemical supplier serving pharmaceutical manufacturing needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Hongbo Chemical.